Eastwood Bio-Medical Canada Inc (EBM) — Strategic Asset Allocation Index
Eastwood Bio-Medical Canada Inc (EBM) has a Strategic Asset Allocation Index of 1604.2% as of April 2021. Strategic assets (PP&E of CA$597.08K plus long-term investments of CA$-) total CA$597.08K, measured against net assets of CA$37.22K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See EBM net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Eastwood Bio-Medical Canada Inc Strategic Asset Allocation Index (2018–2020)
This chart shows how Eastwood Bio-Medical Canada Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2018 to 2020. As of April 2021, the index stands at 1604.2%, representing strategic assets of CA$597.08K against net assets of CA$37.22K CAD. For live market cap and overall valuation, see Eastwood Bio-Medical Canada Inc market capitalisation.
Annual Strategic Asset Allocation Index for Eastwood Bio-Medical Canada Inc (2018–2020)
The table below presents the year-by-year Strategic Asset Allocation Index for Eastwood Bio-Medical Canada Inc from 2018 to 2020, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Eastwood Bio-Medical Canada Inc for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 141.4% | CA$649.58K | CA$649.58K | CA$- | CA$459.27K | ▲ +106.6 pp |
| 2019 | 34.8% | CA$456.60K | CA$456.60K | CA$- | CA$1.31 Million | ▲ +20.9 pp |
| 2018 | 13.9% | CA$262.59K | CA$262.59K | CA$- | CA$1.89 Million | — |